Scaling Biomanufacturing Challenges
Arye discusses the complexities of scaling biomanufacturing from lab to large-scale production, highlighting that protocols effective at one-liter scales often fail at larger volumes. He emphasizes that the majority of costs arise from downstream processing rather than fermentation itself. Additionally, Arye clarifies the distinction between synthetic biology and traditional biotech, noting how synthetic biology has broadened to include applications in food, agriculture, and biomaterials.In this clip
From this podcast
Catalyst with Shayle Kann
Microbes, meat and materials: biotech meets climatetech
Related Questions